table network network 2
demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderateCOVID-19 severe or critically
hydroxychloroquine Magagnoli ... Arshad ... Fontana OAHU-COVID19 IRCT20200428047228N1 // U07 Singh Geleris Chen CCAP-1 HYCOVID Gonzalez ... Novales NO COVID-19 ... Duke university HCQ HAHPS RECOVERY Kalligeros ARCHAIC -hydroxychloroquine PROTECT A ORCHID Paccoud Belgian Collaborative Group on COVID-19 Duke University hydroxychloroquine/azithromycine Sbidian ... Abd-Elsalam PROTECT B Tang SOLIDARITY ... Cravedi TEACH Gautret et al. ChiCTR2000030054-HCQ ... IRCT20150808023559N20 IRCT20150808023559N20 NCT04376814-Group A NCT04376814-Group A NOR-Solidarity ... Zhaowei Chen Min Coalition Covid-19 Brazil I ... Dubee NCT04333654 Kamran HC-nCoV ... FACCT Trial Sarhan Yu REMAP-CAP-HCQ HYDRA ... Mahevas Sarhan

1 studies excluded by filtering options 2

5864 HYDRA, 2020 210excludedrisk of bias not avaialble

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons